RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis
Máté Nászai,
Karen Bellec,
Yachuan Yu,
Alvaro Román-Fernández,
Emma Sandilands,
Joel Johansson,
Andrew D Campbell,
Jim C Norman,
Owen J Sansom,
David M Bryant,
Julia B Cordero
Affiliations
Máté Nászai
Wolfson Wohl Cancer Research Centre, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
Karen Bellec
Wolfson Wohl Cancer Research Centre, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
Yachuan Yu
Wolfson Wohl Cancer Research Centre, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Alvaro Román-Fernández
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Emma Sandilands
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Joel Johansson
Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Andrew D Campbell
Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Jim C Norman
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
Wolfson Wohl Cancer Research Centre, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
RAS-like (RAL) GTPases function in Wnt signalling-dependent intestinal stem cell proliferation and regeneration. Whether RAL proteins work as canonical RAS effectors in the intestine and the mechanisms of how they contribute to tumourigenesis remain unclear. Here, we show that RAL GTPases are necessary and sufficient to activate EGFR/MAPK signalling in the intestine, via induction of EGFR internalisation. Knocking down Drosophila RalA from intestinal stem and progenitor cells leads to increased levels of plasma membrane-associated EGFR and decreased MAPK pathway activation. Importantly, in addition to influencing stem cell proliferation during damage-induced intestinal regeneration, this role of RAL GTPases impacts on EGFR-dependent tumourigenic growth in the intestine and in human mammary epithelium. However, the effect of oncogenic RAS in the intestine is independent from RAL function. Altogether, our results reveal previously unrecognised cellular and molecular contexts where RAL GTPases become essential mediators of adult tissue homeostasis and malignant transformation.